AstraZeneca completes acquisition of Alexion Pharmaceuticals
AstraZeneca completed the acquisition of Alexion Pharmaceuticals, (Alexion). The closing of the acquisition marks the company's entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca
Alexion Pharmaceuticals | 23/07/2021 | By Darshana | 179
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy